We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Featured News

 

Latest News

TransTech Pharma Selects Genedata to Enhance High Throughput Screening Analysis
News   Dec 14, 2005

Scientists at TransTech Pharma will use Screener to enhance their efforts to develop small molecules as therapeutics.

READ MORE

InforSense and Tripos Announce Alliance to Improve Drug Discovery Decision-Making
News   Dec 13, 2005

This alliance enables customers to access and integrate Tripos' discovery informatics technologies within InforSense KDE.

READ MORE

Applied Precision Signs OEM and Distribution Agreement with Cellomics
News   Dec 13, 2005

Applied Precision will exclusively supply the cellWoRx imaging scanner to Cellomics.

READ MORE

Applied Precision Showcases Cellular Imaging Lab at ASCB 2005
News   Dec 13, 2005

ASCB attendees will also be able to review cellWoRx™- now coupled with Cellomics' vHCS™ Analysis Toolbox.

READ MORE

Domantis Raises $29 Million in Series B Financing
News   Dec 12, 2005

Domantis has raised a total of $83 million since its inception in 2000.

READ MORE

MorphoSys Announces Extension of Antibody Collaboration with Bayer
News   Dec 09, 2005

MorphoSys grants Bayer access to its proprietary HuCAL GOLD® antibody library.

READ MORE

Elsevier MDL Upgrades MDL® Isentris® Platform
News   Dec 08, 2005

Isentris 1.4 release improves researchers' ability to collate and manage data within scientific workflows.

READ MORE

Galapagos Extends Its Collaboration with Amgen Throughout 2006
News   Dec 08, 2005

Galapagos' service division BioFocus will continue to provide Amgen with drug discovery expertise.

READ MORE

Xceleron and Servier Sign Agreement to Accelerate Drug Development
News   Dec 07, 2005

The Agreement covers the provision by Xceleron of accelerator mass spectrometry services to assist Servier.

READ MORE

MedImmune Licenses BioWa’s POTELLIGENT™ Technology
News   Dec 07, 2005

BioWa will provide MedImmune with commercial rights to use the technology to enhance antibody-dependent cellular cytotoxicity.

READ MORE